Evolution and mutations of hepatitis B virus quasispecies in genotype B and C during vertical transmission

Journal of Medical Virology

Volumn 88, Issue 6, 2016, Pages 1018-1026

  Wu, Quanxin ^a,b,c   Xu, Cheng ^a,b   Li, Junnan ^a   Li, Li ^a   Yan, Guohua ^a,b   Yue, Liangliang ^d   Zeng, Yi ^e   Huang, Hongfei ^a,b   Deng, Guohong ^a,b   Wang, Yuming ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing   (China)

^c WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^d SOUTHWEST FORESTRY UNIVERSITY   (China)

^e Department of General Surgery   (China)

Author keywords

HBV mutation; Immune escape; Perinantal; Quasispecies; Transmission

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA; HEPATITIS B SURFACE ANTIGEN; PRESURFACE PROTEIN 1, HEPATITIS B SURFACE ANTIGEN; PROTEIN PRECURSOR;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; C/PREC GENE; CLINICAL ARTICLE; EVOLUTION; FEMALE; GENETIC DISTANCE; GENETIC POLYMORPHISM; HEPATITIS B; HEPATITIS B VIRUS GENOTYPE B; HEPATITIS B VIRUS GENOTYPE C; HUMAN; IMMUNE EVASION; INFANT; MALE; MIXED INFECTION; MOTHER; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; P GENE; PHYLOGENETIC TREE; PRES1 GENE; VERTICAL TRANSMISSION; VIRUS GENE; VIRUS MUTATION; YOUNG ADULT; BLOOD; CHRONIC HEPATITIS B; DNA SEQUENCE; GENETICS; GENOTYPE; HEPATITIS B VIRUS; MOLECULAR EVOLUTION; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; TRANSMISSION; VIROLOGY;

ADULT; COINFECTION; DNA, VIRAL; DRUG RESISTANCE, VIRAL; EVOLUTION, MOLECULAR; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE EVASION; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHERS; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTEIN PRECURSORS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84961994358     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24424     Document Type: Article

References (37)

1. Beckebaum S, Malago M, Dirsch O, Cicinnati VR, Trippler M, Lampertico P, Lama N, Treichel U, Gerken G, Broelsch CE. 2003. Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation. Clini Transplant 17:554-559.
2. Borgia G, Carleo MA, Gaeta GB, Gentile I. 2012. Hepatitis B in pregnancy. World J Gastroenterol 18:4677-4683.
3. Buchanan C, Tran TT. 2010. Management of chronic hepatitis B in pregnancy. Clin Liver Dis 14:495-504.
4. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ. 2004. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53:1494-1498.
5. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 336:1855-1859.
6. Chen GG, Li MY, Ho RL, Chak EC, Lau WY, Lai PB. 2005. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma. J Clin Virol 34:7-12.
7. Chou YC, Yu MW, Wu CF, Yang SY, Lin CL, Liu CJ, Shih WL, Chen PJ, Liaw YF, Chen CJ. 2008. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 57:91-97.
8. Chu CJ, Hussain M, Lok AS. 2002. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122:1756-1762.
9. Dong Y, Liu SL, Zhai XJ, Zhu FC, Pan H, Yu JX, Chen YZ, Xie YR, Zhang XY, Zhang HM, Li LJ, Wang H, Ruan B. 2009. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China. J Med Virol 81:1517-1524.
10. Domingo E, Martin V, Perales C, Grande-Perez A, Garcia-Arriaza J, Arias A. 2006. Viruses as quasispecies: Biological implications. Curr Top Microbiol Immunol 299:51-82.
11. Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, Yeh SH, Yu H, Xue Y, Chen YX, Liu PG, Ge SX, Zhang J, Xia NS. 2012. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 57:720-729.
12. Ie SI, Thedja MD, Roni M, Muljono DH. 2010. Prediction of conformational changes by single mutation in the hepatitis B virus surface antigen (HBsAg) identified in HBsAg-negative blood donors. Virol J 7:326.
13. Ijaz S, Torre F, Tedder RS, Williams R, Naoumov NV. 2001. Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients. J Med Virol 63:210-216.
14. Jonas MM. 2009. Hepatitis B and pregnancy: An underestimated issue. Liver Int 29:133-139.
15. Kao JH. 2002. Hepatitis B viral genotypes: Clinical relevance and molecular characteristics. J Gastroenterol Hepatol 17:643-650.
16. Li Z, Xie Z, Ni H, Zhang Q, Lu W, Yin J, Liu W, Ding Y, Zhao Y, Zhu Y, Pu R, Zhang H, Dong H, Fu Y, Sun Q, Xu G, Cao G. 2014. Mother-to-child transmission of hepatitis B virus: Evolution of hepatocellular carcinoma-related viral mutations in the post-immunization era. J Clin Virol 61:47-54.
17. Liu BM, Li T, Xu J, Li XG, Dong JP, Yan P, Yang JX, Yan L, Gao ZY, Li WP, Sun XW, Wang YH, Jiao XJ, Hou CS, Zhuang H. 2010. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naive Chinese patients. Antiviral Res 85:512-519.
18. Luongo M, Critelli R, Grottola A, Gitto S, Bernabucci V, Bevini M, Vecchi C, Montagnani G, Villa E. 2015. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: Sequence analysis and therapeutic strategy. J Clin Virol 62:89-91.
19. Mangold CM, Unckell F, Werr M, Streeck RE. 1997. Analysis of intermolecular disulfide bonds and free sulfhydryl groups in hepatitis B surface antigen particles. Arch Virol 142:2257-2267.
20. Martin D, Rybicki E. 2000. RDP: Detection of recombination amongst aligned sequences. Bioinformatics 16:562-563.
21. Mendy M, D'Mello F, Kanellos T, Oliver S, Whittle H, Howard CR. 2008. Envelope protein variability among HBV-Infected asymptomatic carriers and immunized children with breakthrough infections. J Med Virol 80:1537-1546.
22. Mu SC, Lin YM, Jow GM, Chen BF. 2009. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 50:264-272.
23. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. 2001. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135:796-800.
24. Nylander JAA. 2004. MrModeltest V2. Evolutionary Biology Centre, Uppsala University: Program distributed by the author.
25. Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Van Ranst M, Tacke F. 2014. Molecular identification of hepatitis B virus genotypes/subgenotypes: Revised classification hurdles and updated resolutions. World J Gastroenterol 20:7152-7168.
26. Ronquist F, Teslenko M, van der Mark P, Ayres DL, Darling A, Hohna S, Larget B, Liu L, Suchard MA, Huelsenbeck JP. 2012. MrBayes 3.2: Efficient Bayesian phylogenetic inference and model choice across a large model space. Syst Biol 61:539-542.
27. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R. 2003. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496-2497.
28. Sticchi L, Caligiuri P, Cacciani R, Alicino C, Bruzzone B. 2013. Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants. Hum Vaccin Immunother 9:568-571.
29. Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, Kanda T, Fukai K, Kato M, Saisho H. 2003. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37:19-26.
30. Swofford D. 1998. PAUP*: Phylogenetic analysis using parsimony; 4.0b10.
31. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599.
32. Tang YZ, Liu L, Pan MM, Wang YM, Deng GH. 2011. Evolutionary pattern of full hepatitis B virus genome during sequential nucleos(t)ide analog therapy. Antiviral Res 90:116-125.
33. Watanabe K, Takahashi T, Takahashi S, Okoshi S, Ichida T, Aoyagi Y. 2005. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations. J Gastroenterol Hepatol 20:441-449.
34. Wen WH, Chen HL, Ni YH, Hsu HY, Kao JH, Hu FC, Chang MH. 2011. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization. Hepatology 53:429-436.
35. Wu Q, Huang H, Sun X, Pan M, He Y, Tan S, Zeng Y, Li L, Deng G, Yan Z, He D, Li J, Wang Y. 2015. Telbivudine prevents vertical transmission of hepatitis B virus from women high viral loads: A prospective long-term study. Clin Gastroenterol Hepatol 13:1170-1176.
36. Yin J, Xie J, Liu S, Zhang H, Han L, Lu W, Shen Q, Xu G, Dong H, Shen J, Zhang J, Han J, Wang L, Liu Y, Wang F, Zhao J, Zhang Q, Ni W, Wang H, Cao G. 2011. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol 106:81-92.
37. Yuan J, Zhou B, Tanaka Y, Kurbanov F, Orito E, Gong Z, Xu L, Lu J, Jiang X, Lai W, Mizokami M. 2007. Hepatitis B virus (HBV) genotypes/subgenotypes in China: Mutations in core promoter and precore/core and their clinical implications. J Clin Virol 39:87-93.